tirzepatide

GLP-1 receptor agonists are not just making waves in weight management and diabetes care—they’re showing potential in addressing various forms of addiction. By modulating dopamine pathways in the brain, these medications could help reduce cravings and compulsive behaviours across a spectrum of addictions.

There are no direct head-to-head trials between semaglutide (Wegovy) and tirzepatide (Mounjaro). So, what we have to date is like comparing two world-class boxers and asking who is the best, when they have never actually fought each other. This study uses statistical analysis to virtually “match” and “pair-up” participants in different trials to provide a better comparison of the effectiveness of the two drugs.

Understanding Obstructive Sleep Apnoea (OSA) Obstructive Sleep Apnoea (OSA) is a common sleep disorder where your airway repeatedly gets blocked during sleep, leading to interrupted breathing. This can cause loud snoring, choking or gasping for air, and excessive daytime sleepiness. Untreated OSA can lead to serious health issues like heart disease and stroke. How is […]

How to boost your clinic income. Medical Weight Loss is a great way to improve clinic income and to also add a more medical emphasis to your aesthetic clinic.